Company news
Opthea Limited news in 2020
Opthea Limited's news releases, calls and decks from 2020, newest first.
Opthea Receives A$8.5m R&D Tax Incentive
October 26, 2020
Opthea Announces Closing of US Initial Public Offering
October 20, 2020
Opthea Announces Pricing of US Initial Public Offering
October 18, 2020
Opthea Launches Proposed US Initial Public Offering
October 12, 2020
Results of Meeting
October 11, 2020
Opthea Files Registration Statement for Proposed US IPO
September 24, 2020
Opthea Full Year Financial Report 2020
August 27, 2020
Opthea Announces Plans for Potential US listing and IPO
August 23, 2020
Opthea Completes Successful FDA and EMA Meetings for Phase 3
August 20, 2020
Corporate Presentation of Ph1b/2a DME Trial Data (ASRS)
July 26, 2020
S&P DJI Announces June 2020 Quarterly Rebalance
June 11, 2020
Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
June 9, 2020
Opthea Completes Patient Dosing in Phase 2a DME Trial
March 29, 2020
Opthea Completes Recruitment in Ph2a Trial of OPT-302 in DME
January 6, 2020
Decks in 2020
- Investor Presentation (September 2020)
Investor deck · 72 slides · September 2020
- Investor Presentation (July 2020)
Investor deck · 25 slides · Jul 27, 2020